A national survey of immunization practices following allogeneic bone marrow transplantation Academic Article uri icon

Overview

MeSH Major

  • Bone Marrow Transplantation
  • Vaccination

abstract

  • Despite convincing evidence that patients lose protective antibodies to vaccine-preventable diseases following allogeneic BMT and accumulating data showing the safety and efficacy of many vaccines after BMT, vaccines are underutilized and schedules vary widely at US transplant centers. National guidelines for optimal doses and timing of vaccines after BMT are warranted.

publication date

  • April 9, 1997

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9087470

Additional Document Info

start page

  • 1148

end page

  • 51

volume

  • 277

number

  • 14